René Caballero

M Martin 1 collaboration

C Zielinski 1 collaboration

M Ruiz-Borrego 1 collaboration

E Carrasco 1 collaboration

N Turner 1 collaboration

E M Ciruelos 1 collaboration

M Muñoz 1 collaboration

B Bermejo 1 collaboration

M Margeli 1 collaboration

A Anton 1 collaboration

Z Kahan 1 collaboration

T Csöszi 1 collaboration

M I Casas 1 collaboration

L Murillo 1 collaboration

S Morales 1 collaboration

E Alba 1 collaboration

E Gal-Yam 1 collaboration

A Guerrero-Zotano 1 collaboration

L Calvo 1 collaboration

J de la Haba-Rodriguez 1 collaboration

M Ramos 1 collaboration

I Alvarez 1 collaboration

A Garcia-Palomo 1 collaboration

C Huang Bartlett 1 collaboration

M Koehler 1 collaboration

R Caballero 1 collaboration

M Corsaro 1 collaboration

X Huang 1 collaboration

J A Garcia-Sáenz 1 collaboration

J I Chacón 1 collaboration

C Swift 1 collaboration

C Thallinger 1 collaboration

M Gil-Gil 1 collaboration

Manuel Ruiz-Borrego 1 collaboration

Begoña Jimenez 1 collaboration

Silvia Antolín 1 collaboration

Jose A García-Saenz 1 collaboration

Jesús Corral 1 collaboration

Yolanda Jerez 1 collaboration

José Trigo 1 collaboration

Ander Urruticoechea 1 collaboration

Helena Colom 1 collaboration

Nuria Gonzalo 1 collaboration

Carmen Muñoz 1 collaboration

Sara Benito 1 collaboration

Rosalía Caballero 1 collaboration

Susana Bezares 1 collaboration

Eva Carrasco 1 collaboration

Federico Rojo 1 collaboration

Miguel Martín 1 collaboration

Macarena Lozano-Oyola 1 collaboration

Francisco Javier Blancas 1 collaboration

Mercedes González 1 collaboration

Rafael Caballero 1 collaboration

Publications (3)

Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial-PEARL.

A phase Ib study of sonidegib (LDE225), an oral small molecule inhibitor of smoothened or Hedgehog pathway, in combination with docetaxel in triple negative advanced breast cancer patients: GEICAM/2012-12 (EDALINE) study.

Sustainable tourism tags to reward destination management.

Réseau de co-auteurs